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Abstract
Background: We have reported arginine-sensitive regulation of LAT1 amino acid transporter (SLC 7A5) in
normal rodent hepatic cells with loss of arginine sensitivity and high level constitutive expression in tumor cells.
We hypothesized that liver cell gene expression is highly sensitive to alterations in the amino acid
microenvironment and that tumor cells may differ substantially in gene sets sensitive to amino acid availability. To
assess the potential number and classes of hepatic genes sensitive to arginine availability at the RNA level and
compare these between normal and tumor cells, we used an Affymetrix microarray approach, a paired in vitro
model of normal rat hepatic cells and a tumorigenic derivative with triplicate independent replicates. Cells were
exposed to arginine-deficient or control conditions for 18 hours in medium formulated to maintain differentiated
function.
Results: Initial two-way analysis with a p-value of 0.05 identified 1419 genes in normal cells versus 2175 in tumor
cells whose expression was altered in arginine-deficient conditions relative to controls, representing 9–14% of
the rat genome. More stringent bioinformatic analysis with 9-way comparisons and a minimum of 2-fold variation
narrowed this set to 56 arginine-responsive genes in normal liver cells and 162 in tumor cells. Approximately half
the arginine-responsive genes in normal cells overlap with those in tumor cells. Of these, the majority was
increased in expression and included multiple growth, survival, and stress-related genes. GADD45, TA1/LAT1,
and caspases 11 and 12 were among this group. Previously known amino acid regulated genes were among the
pool in both cell types. Available cDNA probes allowed independent validation of microarray data for multiple
genes. Among genes downregulated under arginine-deficient conditions were multiple genes involved in
cholesterol and fatty acid metabolism. Expression of low-density lipoprotein receptor was decreased in both
normal and tumor cells.
Conclusion: Arginine-sensitive regulation appears to be an important homeostatic mechanism to coordinate cell
response and nutrient availability in hepatic cells. Genes predicted as arginine-responsive in stringent microarray
data analysis were confirmed by Northern blot and RT-PCR. Although the profile of arginine-responsive genes is
altered and increased, a considerable portion of the "arginome" is maintained upon neoplastic transformation.
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Background
Cell growth is dependent upon availability of essential
amino acids for protein synthesis and this relationship
makes amino acid-dependent control of gene expression
an important area of study [1-3]. We previously reported
that levels of the tumor-associated glycoprotein amino
acid transporter, TA1/LAT1/CD98 light chain/SLC7A5,
increase in normal hepatic cells under low arginine condi-
tions, while levels are constitutive and high in hepatic
tumor cells [4,5]. Upregulation of this gene is associated
with multiple cancer types and we and others have
hypothesized that increased expression may provide an
adaptive advantage in the tumor microenvironment
where nutrients are limiting [6,7]. Loss of nutrient-sensi-
tive regulation may comprise a subset of the loss of
responsiveness to negative growth signals or autonomy
from positive growth factors, characteristic of cancer cells
in general [8]. We thus manipulated arginine concentra-
tion in a culture medium that maintains hepatic differen-
tiation as a means to investigate, using a paired normal
and tumorigenic cell type, how many and what types of
hepatic genes are responsive to a transient change in
amino acid levels. Affymetrix gene chips and bioinfor-
matic analyses were used in a nutrigenomics approach.
The goals of the study were to: 1) assess the scope of
arginine-responsive hepatic gene expression using a well-
defined in vitro rat model of normal and tumorigenic cells,
2) determine to what extent amino acid responsive regu-
lation is retained upon transformation, and 3) provide a
microarray dataset predicting novel genes and pathways
subject to amino acid (arginine) regulation.
Results and discussion
Triplicate RAE 230 arrays containing a total of 15,923 rat
genes were hybridized for both normal and tumor cells
grown under arginine-sufficient (+) and arginine-deficient
(-) conditions for 18 hours in three independent pair-wise
comparison experiments. Microarray Suite™ 5.0 software
analysis of the resulting datasets revealed a mean of 8611
genes or 54% of the total rat array scored "present"
(expressed) for normal cells versus 8355 genes or 53% in
tumor cells (Table 1). Of the genes expressed, pair-wise
comparisons of Arg + and - conditions revealed no change
in expression for 7042 (82%) of genes in normal cells ver-
sus 6173 (74%) in tumor cells. Using a p-value of 0.05 or
less and pair-wise comparisons for the three experiments
in normal cells, expression of 811 genes increased, 608
decreased and 97 showed marginal change relative to
arginine-sufficient controls. For tumor cells, transient
arginine deficiency resulted in increased expression of
1249 genes, decreased expression of 926 genes, and mar-
ginal changes in 109. Thus, expression of as many as 2175
genes was scored as arginine-sensitive when the data were
analyzed as independent pairs. This represented 8.9% of
genes in normal cells and 13.6% of genes in tumor cells.
At the time of the data collection, nearly half of these
genes lacked complete functional annotation in the rat
genomic database.
Table 1: Microarray Suite analysis of gene regulation in normal vs. tumor cells in response to 18 hr arginine deprivation.
CODE CELL TYPE ARG 
STATUS
ABSENT PRESENT NET 
INCREASE
NET 
DECREASE
MARGINAL NO CHANGE
N1 NORMAL Arg + 7189 8474
N3 "A r g  + 7 1 0 2 8 5 3 6
N5 "A r g  + 7 0 1 0 8 6 6 2
N2 " Arg deficient 7140 8532 1242 876 135 6221
N4 " Arg deficient 7296 8381 358 136 52 7990
N6 " Arg deficient 6601 9082 832 811 105 6914
MEAN Normal 7106 8611 811 608 97 7042
AVEDEV 167 174 302 314 30 632
T1 TUMOR Arg + 7085 8535
T3 "A r g  + 7 0 5 1 8 6 0 7
T5 "A r g  + 7 4 2 3 8 2 2 4
T2 " Arg deficient 6934 8725 1514 1187 119 5715
T4 " Arg deficient 7664 7973 1391 913 117 6186
T6 " Arg deficient 7573 8065 843 678 86 6617
MEAN Tumor 7288 8355 1249 926 109 6173
AVEDEV 265 268 271 174 14 305
Numbers of rat genes in Affymetrix RAE 230 array demonstrating expression, no change, increase, decrease and marginal change. Change in gene 
expression based on p value of 0.05 or less in pair-wise comparisons of three independent datasets. RAE 230 array contains 15,923 genes.Nutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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Because the number of genes in the preliminary analysis
comprised a large portion of the rat genome, additional
filters were applied to the dataset using GeneSpring™ 6.1
and 7.0 software analysis in order to identify the most
reproducible and significant alterations resulting from
transient arginine deficiency. For each cell type, all + sam-
ples were compared to all – samples, resulting in 9 com-
parisons. A concordance threshold of 66% or greater was
set and 'arginine-responsive' increases or decreases were
defined as a change of 2-fold and higher under arginine-
deficient conditions. All other genes expressed were
defined as "no change".
Using these more stringent parameters, the total number
of arginine-responsive genes in normal cells and tumor
cells was significantly reduced, to 56 and 162 respectively.
A summary of the data comparing normal and tumor cells
by functional gene class and direction of change is shown
in Table 2. All 56 and 162 genes in normal and tumor cells
respectively listed by accession numbers and correspond-
ing direction of change relative to arginine-sufficient con-
ditions (I = increase; D = decrease) are listed in
supplemental Tables 4 and 5 [see additional files 1 and 2].
The entire 12 microarray dataset is available in MIAME
format [9] in the NCBI Gene Expression Omnibus (GEO)
database, confirmation #GSE2275. Figure 1 presents Venn
diagrams of overlap between the arginine-responsive gene
subsets of normal and tumor cells. Just over half the
arginine-responsive genes in normal cells are also respon-
sive in tumor cells. A surprising finding was the large
number (133) of additional genes demonstrating
arginine-responsive expression in tumor cells. More than
one third of these were listed as transcribed sequences
with no listed functional information or homology to
known sequences at the time of analysis. Not surprisingly,
genes with increased expression upon arginine depletion
in both normal and tumor cells include a large number of
genes involved in cell cycle and growth regulation, cell
death and apoptosis, and stress response. Several of these
were known amino acid-responsive genes such as asparag-
ine synthetase [10]. Among other genes scoring as
increased in both cell types was growth-arrest DNA dam-
age-inducible 45 alpha (GADD45) and caspase 12. Genes
down-regulated in both normal and tumor cells include
plasminogen activator urokinase and low density lipopro-
tein receptor. Genes that exhibited arginine-responsive
regulation in normal cells but a loss in tumor cells (or vice
versa) may represent 'interesting' subsets in which the
potential contribution of amino-acid regulation to the
malignant phenotype could be explored. Genes whose
expression was altered in tumor cells but not normal cells
included tumor suppressor retinoblastoma-like 2, stress-
response protein 70 kDa heat shock protein precursor and
cell-surface linked signal transducer MAP-kinase phos-
phatase, cell cycle regulator cyclin dependent kinase
inhibitor 2C (p18) and Ras. Genes scoring as changed in
normal but "no change" in tumor cells were mainly in
cholesterol and steroid biosynthesis pathways. Related to
these were farnesyl diphosphate synthase and insulin-
induced gene 1/growth response protein CL-6 (Insig-1/
CL-6), an ER-residing membrane protein that blocks the
proteolytic activation of sterol-regulatory element binding
protein (SREBPs) transcription factors that activate the
synthesis of fatty acids and cholesterol [11-13].
Independent verification of expression was sought for a
subset of genes via Northern blot analysis (Figure 2) and
RT-PCR (Figure 3). Genes were selected in which cDNA
probes were available with appropriate known controls to
validate selected cases in which arginine-deprivation pre-
dicted an increase, decrease or no significant change in
expression. Though the level of expression for some genes
was found to differ substantially between normal and
tumor samples, between arginine + and - conditions
respectively, or between independent experimental repli-
cates, trends predicted in microarray data analysis were
generally validated by the confirmatory RNA expression
analysis and densitometry. That is, LAT1, GADD45 and
4F2 increased in both cell types under conditions of
arginine deprivation; LDLr decreased in both cell types
upon arginine deprivation; LAT2 and GAPDH showed no
significant change in either cell type, though LAT2 expres-
sion was very low in tumor cells; p21 decreased in normal
cells but was below detection limits in tumor cells; far-
nesyl diphosphate synthase (FDPS) decreased in normal
cells but not in tumor cells upon arginine deprivation;
Insig 1 showed large variability with decreases in some
replicates but not in others. The use of different probe sets
between the microarray and Northern or PCR analyses,
differences in quantitation and normalization methodol-
ogy or undetermined other variables may account for dif-
ferences in fold change values observed between these
techniques.
Given its enormous potential for insight into regulatory
physiology, nutrigenomics, the use of genomic tools to
study nutrient-gene interactions, is an area of expanding
interest in health and disease [14-16]. We found global
changes in gene expression when hepatic cells were sub-
jected to short term deficiency of arginine. Arginine, a pre-
cursor of proteins and other compounds critical to normal
metabolism, is considered essential for growth and devel-
opment of many mammals [17,18]. Our experimental
system was one of amino acid imbalance, but not of total
arginine starvation, since the medium was supplemented
with 5% non-dialyzed fetal bovine serum and the expo-
sure to deficient conditions was less than 24 hr. In fact,
arginine-free medium has been widely used as a means to
deplete primary hepatocyte cultures of small numbers of
contaminating nonparenchymal cells because all theNutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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Table 2: Stringent GeneSpring analysis of gene regulation in normal vs. tumor cells in response to 18 hr arginine deprivation.
Class (n) Example Change in Normal Change in Tumor
Cell Growth and
Maintenance (10) growth arrest and DNA-damage-inducible 45 alpha
Rattus norvegicus transcribed sequence with moderate similarity to 
protein
sp:Q9H3K2 (H.sapiens) DER2_HUMAN Dermal papilla derived protein 2
(AA858928)
neuronal cell death inducible putative kinase (NIPK)
Caspase 12
tumor-associated protein 1
solute carrier family 7, member 1
solute carrier family 3, member 2
homocysteine-inducible, endoplasmic reticulum stress-inducible
ubiquitin-like domain member 1
asparagine synthetase
CTL target antigen
Inc Inc
Unclassified (1) Low density lipoprotein receptor Dec Dec
Cell Growth and
Maintenance (28) retinoblastoma-like 2
epithelial calcium channel 1
sequestosome 1
70 kda heat shock protein precursor
protein arginine N-methyltransferase 3(hnRNP methyltransferase S. 
cerevisiae)-like 3
eukaryotic translation initiation factor 4E binding protein 1
protease, serine, 15
B-cell translocation gene 1
5-hydroxytryptamine (serotonin) receptor 3a
MAP-kinase phosphatase (cpg21)
diphtheria toxin receptor
NC Inc
Unclassified (24) growth arrest specific 5
Cell Growth and
Maintenance (12) cyclin dependent kinase inhibitor 2C
solute carrier family 6, member 6
fatty acid Coenzyme A ligase, long chain 3
Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
Topoisomerase (DNA) 2 alpha
adducin 3, gamma
NC Dec
Signal Transduction (2) RAB3D, member RAS oncogene family
Developmental Processes (1) Sperm-associated antigen 5
arginine vasopressin receptor 1A
GATA binding protein 6
Unclassified (21) Nesprin-1
Cell Growth and 
Maintenance (1)
endo-alpha-mannosidase Inc NC
Signal Transduction (2) Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
Rattus norvegicus transcribed sequence with strong similarity to protein 
pir:I55595
(H. sapiens) I55595 splicing factor (BG372903)
Unclassified (7) transmembrane 4 superfamily member 3 (NM_133526)
Cell Growth and 
Maintenance (6)
cytochrome P450, subfamily 51
7-dehydrocholesterol reductase
isopentenyl-diphosphate delta isomerase
sterol-C4-methyl oxidase-like]
farensyl diphosphate synthase
Growth Response protein CL-6 (Insig-1)
Dec NC
'Change' defined as 2 fold and higher increase (+) or decrease (-) in expression from + arg to - arg. 'NC' (No change) defined as all other genes that 
were not differentially expressed with a 2 fold and higher change. Main functional classes are shown in the table, with corresponding representative 
genes in each class. Categorization of genes was performed using GeneSpring software. The number of genes in each class is also shown beside the 
class in parentheses.Nutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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enzymes necessary for arginine synthesis are expressed by
the normal hepatocyte [17]. Importantly, viability was
well preserved over the experimental timeframe (data not
shown). Thus, the observed changes in gene expression
were not the result of impending cell death but are more
likely a response to nutrient stress.
Stress caused by changes in the cellular environment
including nutrients is recognized as an important physio-
logical parameter to which eukaryotic cells have evolved
complex cellular responses [19-22]. Although it is not
possible to differentiate primary effects from secondary
during this timeframe, overall, cell growth and mainte-
nance, metabolism, stress-related and apoptotic gene
classes appear most predominant. Genes associated with
metabolism and stress response that were present in the
rat chip and showed a significant p-value for altered
expression upon arginine deprivation are presented in
Table 3. Because many genes associated with stress
response in human cells were not present or identifiable
on the RAE 230 chip however, it is not possible to fully
assess arginine response of these gene sets in this model.
With the exception of a subset of genes involved in choles-
terol and steroid biosynthesis, there was no overall loss of
amino-acid responsive regulation in the tumor cells com-
pared to normal cells. In fact, to our surprise, in assessing
the entire rat transcriptome a larger proportion of genes
was found to be arginine-responsive in tumor cells com-
pared to the normal cell from which they were derived.
The use of this paired cell set in the experimental design is
an important consideration as it minimizes variation due
to other factors such as genetic strain or viral exposure.
Our data not only add to the nutrigenomics literature and
database in general, but also extend the finding of others
in which changes in amino acid composition or starvation
have been associated with specific patterns of hepatic gene
response both in vivo and in vitro [23-25]. The data suggest
that arginine deprivation of hepatic normal and tumor
cells may induce an initial stress response very similar to
the well known endoplasmic reticulum (ER) stress-
response described in eukaryotic cell types [19]. The loca-
tion of products of several arginine-responsive genes
including caspase 12, LDLr, Insig-1 and cholesterol/ster-
oid biosynthesis all in the ER are consistent with the
induction of a potent luminal ER stress response in both
normal and tumor cells. Interestingly, although both cell
types appear able to modulate LDLr, a regulator of choles-
terol and steroid biosynthesis, in response to arginine
deprivation, at some point downstream of the stress path-
way, tumor cells appear to deviate by losing regulation of
Insig-1 and metabolic genes directly involved in choles-
terol and steroid biosynthesis. While it is tempting to
speculate that loss of regulation within this gene cluster
may be adaptive in a tumor microenvironment of limited
nutrient availability, permitting malignant cells to persist
in membrane synthesis required for repeated cell divi-
sions, endocytosis, fusion or other processes, the rele-
vance of these observed changes in gene expression in vitro
to potential alterations in hepatic function and tumor
growth in vivo are currently unknown. This hypothesis is
testable but beyond the limits of the current project. The
generation and reporting of nutrigenomic data is undeni-
ably descriptive. However, datasets such as this one are
valuable in that they facilitate hypothesis generation and
Comparison of arginine-responsive gene sets in normal and tumor cells Figure 1
Comparison of arginine-responsive gene sets in normal and tumor cells. (A) a: Arginine-responsive genes in Normal 
Rat Hepatic Cells; b: Arginine-responsive genes in both Normal and Tumor Rat Hepatic Cells; c: Arginine-responsive genes in 
Tumor Rat Hepatic Cells. (B) a: Genes with expression Increase in Normal b: Genes with expression Increase in both Normal 
and Tumor; c: Genes with expression Increase in Tumor. (C) a: Genes with expression Decrease in Normal; b: Genes with 
expression Decrease in both Normal and Tumor; c: Genes with expression Decrease in Tumor.
a (20) 
b (28)
c (80) 
BC
c (53) 
a (7) 
A
a (27) 
b (29) 
c (133)
b( 1 )Nutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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Northern blot confirmation of selected rat hepatic gene expression in normal and tumor cells in response to 18 hr arginine  deprivation Figure 2
Northern blot confirmation of selected rat hepatic gene expression in normal and tumor cells in response to 
18 hr arginine deprivation. Total RNA (10 ug per culture condition) was electrophoresed and blotted to nylon membranes 
for sequential hybridization with P-32 labeled cDNA probes for p21, GADD45, Insig-1, 4F2, LAT1, LAT2 and GAPDH. Autora-
diographic exposures shown represent maximal differences observed between + and - arginine conditions. The ethidium bro-
mide stained blot prior to hybridization is shown below for comparison of loading between lanes and evidence of intact RNA 
quality.
p21
GADD45
Insig-1
4F2
LAT1
LAT2
GAPDH
28S
18S
Normal Tumor
Arginine placenta
liver
pooled RLNutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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RT-PCR confirmation of selected rat hepatic gene expression in normal and tumor cells in response to 18 hr arginine depriva- tion Figure 3
RT-PCR confirmation of selected rat hepatic gene expression in normal and tumor cells in response to 18 hr 
arginine deprivation. Semi-quantitative Reverse Transcription Polymerase Chain Reaction was used to assess relative 
expression of rat LDLr, farnesyl diphosphate synthase (FDPS), GADD45, Insig-1, and GAPDH for cells cultured with (+) or 
without (-) arginine, Adult liver served as a positive control. DNase treated total RNA was reverse-transcribed with and with-
out (negative control) reverse transcriptase. A. Electrophoresis of PCR products was performed in 2% agarose, 1× TAE gel 
and visualized by ethidium bromide staining; 1 kb DNA marker was used to verify size of the PCR products. B. Densitometry 
of gel bands was assessed via LabWorks Software and values were ratioed to GAPDH to provide relative comparisons 
between Arginine + and Arginine - conditions.
+ - + -
L
I
V
E
R
Normal Tumor
Arginine
LDLr
FDPS
GADD45
Insig-1
GAPDH
531 bp
656 bp
706 bp
447 bp
452 bp
1Kb
L
A
D
D
E
R
A
2.71 1.29 0.63 2.84 Liver
0.92 1.10 0.34 0.97 Tumor -Arg
0.89 0.87 0.31 1.83 Tumor+Arg
1.20 0.97 0.15 0.14 Normal -Arg
1.36 0.43 0.77 1.29 Normal+Arg
INSIG
GADD4
5 FDPS LDLR
Genes Normalized to GAPDH BNutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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Table 3: Arginine sensitivity of rat hepatic cells for known stress response-linked genes.
A. Normal Hepatic Cells
Annotation Gene name Affymetrix ID Change P value
Metabolism (Cholesterol biosynthesis) farensyl diphosphate synthase 1370808_at ↓ 0.00002
farnesyl diphosphate farnesyl transferase 1 1387119_at ↓ 0.00011
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 1373243_at ↓ 0.00002
cytochrome P450, subfamily 51 1368232_at ↓ 0.00002
mevalonate pyrophosphate decarboxylase 1375852_at ↓ 0.00043
7-dehydrocholesterol reductase 1386990_at ↓ 0.00013
mevalonate kinase 1388218_at ↓ 0.00002
isopentenyl-diphosphate delta isomerase 1367839_at ↓ 0.00002
diaphorase 1 1372012_at ↓ 0.00077
Sterol 14 alpha-demethylase (CYP51) 1387020_at ↓ 0.00002
3-hydroxy-3-methylglutaryl-Coenzyme A reductase 1367932_at ↓ 0.00002
phenylalkylamine Ca2+ antagonist (emopamil) binding protein 1367667_at ↓ 0.00021
cytochrome P450, subfamily 51 1368189_at ↓ 0.00002
mevalonate kinase 1368878_at ↓ 0.00120
low density lipoprotein receptor 1388872_at ↓ 0.00021
isopentenyl-diphosphate delta isomerase 1368020_at ↓ 0.00002
Metabolism and energy pathways ATP citrate lyase 1367854_at ↓ 0.00002
Metabolism (Urea Cycle) arginase 1 1368266_at ↓ 0.000492
glutamate dehydrogenase 1 1370200_at ↓ 0.00002
heterogeneous nuclear ribonucleoprotein A/B 1367754_s_at ↓ 0.001651
ornithine aminotransferase 1367729_at ↓ 0.002753
argininosuccinate lyase 1368916_at ↓ 0.015426
Growth arrest and DNA damage inducible 
gene
Gadd45g-predicted 1388792_at ↓ 0.00024
Gadd45b-predicted 1372016_at ↓ 0.00778
Gadd45gip_1predicted 1371896_at ↓ 0.00077
Stress Response growth response protein (CL-6) 1367894_at ↓ 0.00002
voltage-dependent anion channel 1 1386909_a_at ↓ 0.00107
Apoptosis ankyrin-like repeat protein 1367664_at ↓ 0.00005
B. Hepatic Tumor CellsNutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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Annotation Gene name Affymetrix ID Change P value
Metabolism (Cholesterol biosynthesis) farnesyl diphosphate farnesyl transferase 1 1367839_at ↓ 0.00110
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 1367932_at ↓ 0.00002
cytochrome P450, subfamily 51 1367979_s_at ↓ 0.00014
7-dehydrocholesterol reductase 1368189_at ↓ 0.00043
isopentenyl-diphosphate delta isomerase 1368878_at ↓ 0.00004
protein kinase, AMP-activated, alpha 1 catalytic subunit 1369104_at ↓ 0.05055
diaphorase 1 1370808_at ↓ 0.00304
Dhcr24-predicted 1372012_at ↓ 0.01202
phenylalkylamine Ca2+ antagonist (emopamil) binding protein 1386990_at ↓ 0.00165
cytochrome P450, subfamily 51 1387020_at ↓ 0.00650
low density lipoprotein receptor 1388218_at ↓ 0.00002
mevalonate pyrophosphate decarboxylase 1368020_at ↑ 0.03578
Metabolism and energy pathways ATP citrate lyase 1367854_at ↓ 0.00002
Metabolism (Urea Cycle) glutamate dehydrogenase 1 1370200_at ↓ 0.00359
glutamate dehydrogenase 1 1387878_at ↓ 0.00021
ornithine aminotransferase 1367729_at ↓ 0.00002
arginase 1 1368266_at ↓ 0.00061
Growth arrest & DNA damage inducible 
gene
Gadd45g-predicted 1388792_at ↓ 0.00249
Gadd45gip_1predicted 1371896_at ↓ 0.00133
Stress Response oxygen regulated protein (150 kD) 1370665_at ↓ 0.00141
solute carrier family 2, (facilitated glucose transporter) 
member 8
1368286_at ↓ 0.00049
growth response protein (CL-6) 1367894_at ↓ 0.00004
insulin induced gene 2 1389377_at ↑ 0.02475
protease, serine, 25 1367478_at ↑ 0.00004
Apoptosis ankyrin-like repeat protein 1367664_at ↓ 0.01202
glycogen synthase kinase 3 beta 1370267_at ↓ 0.00249
valosin-containing protein 1367455_at ↓ 0.03841
Genes were selected based on key word categories/annotations shown and search of Affymetrix rat gene chip probes. Not all genes associated 
with stress response in human cells are included or identifiable in the rat gene chip. Genes scoring as absent in all 6 normal or tumor samples were 
eliminated from further analysis. For genes scoring as present, the average value of (+) arginine and (-) arginine was calculated for three replicate 
samples. Direction of change in expression upon arginine deprivation and the associated p value for such change is presented.
Table 3: Arginine sensitivity of rat hepatic cells for known stress response-linked genes. (Continued)Nutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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further research. Much more study is needed to define spe-
cific genes and mechanistic pathways linking amino acids
and other dietary nutrients to cancer risk.
Methods
Cell culture
The rat hepatocyte normal diploid cell line WB344 ("nor-
mal") and GP7TB, a chemically-transformed derivative
capable of generating hepatic tumors upon transplanta-
tion to syngeneic rats ("tumor"), were obtained from the
laboratory of Dr. William Coleman, Dept. Pathology,
University of North Carolina, Chapel Hill and maintained
as previously described [5]. To assess arginine-responsive
gene expression, at no more than 80% confluence, media
was removed and cells were rinsed briefly with a custom
formulation of Chee's Essential Medium (CEM) without
arginine (GIBCO Invitrogen Corp., Carlsbad, CA).
Medium was then replaced with CEM with or without L-
Arginine HCl at 0.168 gm/liter for an additional 18 hours
at 37 C and 5% CO2. Media included 5% fetal bovine
serum. The CEM media formulation was utilized because
it has been demonstrated to maintain differentiated func-
tion and gene expression in cultured hepatic cells [4].
RNA isolation and microarray analysis
Cells were harvested by lysis-extraction of total RNA with
TriReagent (Molecular Research Center, Inc., Cincinnati,
OH). RNA quantity and quality were assessed by absorb-
ance at 260 and 280 nm using a Genesys 5 spectropho-
tometer (Spectronic, Leeds, UK). Electrophoresis of the
RNA samples followed by ethidium bromide staining was
used to further evaluate RNA samples. Only non-degraded
RNAs without DNA contamination were utilized. Five μg
of total RNA were converted to the first strand of cDNA by
using SuperScript II RT (Invitrogen Corporation,
Carlsbad, CA), and gel-purified T7-oligo dT(24) (W.M.
Keck Foundation, New Haven, CT) as the primer. Second
strand synthesis was performed using E coli Polymerase I,
DNA ligase, E coli RNA H and T4 DNA Polymerase
according to the manufacturer's instructions and reagents
in the SuperScript Double-Stranded cDNA Synthesis Kit
(Invitrogen). The resulting cDNA was purified by extrac-
tion with (25:24:1) phenol: chloroform: isoamyl alcohol
(Ambion, Inc., Austin, TX), separation of the aqueous
phase using phase lock gels and precipitation in ethanol.
The purified cDNA subsequently served as template for
production of biotin labeled cRNA transcript using the
BioArray High Yield RNA Transcript Labeling Kit (ENZO
Biochemical, New York, NY) and biotin-labeled UTP and
CTP. Labeled cRNA was isolated using the RNeasy Mini
Kit columns (Qiagen, Valencia, CA), quantified for purity,
concentration and yield and subsequently fragmented in
100 mM potassium acetate-30 mM potassium acetate-40
mM Tris-acetate (pH 8.1) for 35 minutes at 94 C to gener-
ate 35–200 bp fragments, suitable for hybridization.
Eukaryotic Target Hybridization was accomplished with
10 μg of fragmented cRNA, eukaryotic hybridization con-
trols, herring sperm DNA (Promega Biosciences, Inc., San
Luis Obsipo, CA), acetylated BSA (Invitrogen), 2× hybrid-
ization buffer and DEPC treated water to make the cock-
tail final concentration 100 mM MES and 1 M [Na+].
Following clarification of the cocktail by heating and cen-
trifugation, rat 230A expression arrays (Affymetrix, Santa
Clara, CA) were loaded with the target cRNA cocktail and
rotated at 60 rpm for 16 hours at 45 C. Following hybrid-
ization, the cocktail was removed and the microarrays
were washed with Non-stringent buffer [6× SSPE, 0.01%
Tween 20 (Pierce, Rockford, IL) 0.005% Antifoam (Sigma,
St Louis, MO)] at 30 C and Stringent buffer (100 mM
MES, 0.1 M [Na+], 0.01% Tween 20) at 50 C in a Affyme-
trix GeneChip Fluidics Station 400 according to the man-
ufacturer's protocol. Microarrays were subsequently
stained with Streptavidin-conjugated Phycoerythrin
(SAPE, Invitrogen, Carlsbad, CA) and staining intensity
was antibody amplified using a biotinylated anti-strepta-
vidin antibody (Vector Laboratories, Burlingame, CA)
according to Affymetrix protocols. The GeneChips were
scanned at 570 nm using the Agilent Technologies
G2500A GeneArray scanner with MicroArray Suite soft-
ware. All hybridization steps were performed at the Brown
University COBRE Center for Genomics and Proteomics
Microarray Facility. Each hybridization was performed in
triplicate from separate RNA prepared from independent
cell cultures of both normal and tumor cells.
Data analysis
Each gene on the 230A array is represented by 20 different
25-base cDNA oligonucleotides complementary to a
cRNA target transcript (perfect match) together with spe-
cificity control oligonucleotides containing a single base
substitution (mismatch) for each perfect-match. The com-
bination of perfect-match and mismatch cDNA oligonu-
cleotides for each gene is termed a probe set. Affymetrix-
defined absolute mathematical algorithms describing per-
fect-match and mismatch hybridization intensities were
used to define each gene as "present" or "absent" and
assign a value. Binding intensity values were scaled to
evaluate differential expression +/- arginine supplementa-
tion. Affymetrix-defined comparison mathematical algo-
rithms determined whether a transcript was classified as
"increased", "decreased", "marginally increased", "mar-
ginally decreased" or "not changed" and a fold change in
expression was calculated. Only genes that had signal
present were selected from the normalized data for further
analysis. This was accomplished using GeneSpring ver-
sion 7.0 (Silicon Genetics, Redwood City, CA) importing
data from Affymetrix MicroArray Suite (MAS 5.0) into
GeneSpring as tab delimited text files. Additional criteria/
filters were used to classify a gene as significantly up- or
down-regulated upon short term arginine starvation: (i)Nutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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expression of a gene must be classified as increased or
marginally increased (or decreased or marginally
decreased) in each replicate compared to the arginine suf-
ficient condition. (ii) The mean fold change for arginine
starvation-induced gene expression must be greater than
2. Mean transcriptional expression of a given gene was cal-
culated as the sum of the fold change in gene expression
for each arginine-minus condition compared to each
arginine-sufficient (normal) condition divided by 6.
Standard errors in mean transcriptional expression of a
gene were also calculated. Comparison between gene
expression levels among groups was done using the Two-
Way ANOVA test.
All microarray data were submitted in compliance with
the Minimal Information about Microarray Experiments
(MIAME) via the Gene Expression Omnibus (GEO) data
repository under the title "A Bioinformatic Analysis of
Arginine-Sensitive Regulation of rat Hepatic Gene Expres-
sion", confirmation #GSE2275 [26]. The MIAME stand-
ard, developed by the Microarray Gene Expression Data
Society, specifies information to permit experimental
reproducibility, standardization of data reporting and
sharing, and allows global access to the original microar-
ray data [9]. Annotation of the differentially expressed
genes and classification into functional groups was done
using the Database for Annotation, Visualization, and
Integrated Discovery (DAVID) program (NIH).
Northern blot confirmation of gene expression
Aliquots (10 μg) of total RNA were size fractionated on
1% agarose/formaldehyde gels as described previously
[4]. After electrophoresis, gels were equilibrated in 1 M
ammonium acetate and RNA was transferred to nylon
membranes. Blots were baked for 2 hr at 80 C. Hybridiza-
tion with cDNA probes was carried out at 42 C in ULT-
RAhyb hybridization solution (Ambion, Austin, TX)
sequentially to random primed, 32P-labeled cDNAs of
interest. Probes for TA1/LAT1, 4F2/CD98 and GAPDH
were described previously [5]. The following partial
cDNAs were generated by PCR from known positive tem-
plate RNA to confirm expression patterns of additional
genes of interest: rat GADD45, a 706 bp PCR fragment
representing nucleotides 1 to 706 [GenBank
NM_024127.1]; rat Insig1/CL6, a 1392 bp fragment rep-
resenting nucleotides 339 to 1730 [GenBank L13619]; rat
LAT2, a 990 bp fragment corresponding to nucleotides
580 to 1570 [GenBank NM_053442.1]. These partial
cDNAs were PCR amplified under individually optimized
conditions with template RNA from positive control rat
tissues or cell lines and subcloned into pCR4 Blunt-TOPO
plasmid vector. Rat p21 cDNA, a 316 bp fragment repre-
senting nucleotides 318 to 634 [GenBank U24174] was
the kind gift of Dr. Phillip Gruppuso, RI Hospital. The
identity of all cDNA probes was confirmed by DNA
sequencing (Keck Biotechnology Laboratory, Yale Univer-
sity (New Haven, CT). Purified inserts were digested from
vector with EcoR1. For LAT2, EcoR1 digestion resulted in
two insert products and the larger, 660 bp fragment was
used as probe. After hybridization and washing, blots
were exposed to X-ray film in the presence of intensifying
screens or a Cyclone Phosphorimager (Model A431201)
(Downers Grove, IL).
RT-PCR confirmation of gene expression
Semi-quantitative Reverse Transcription Polymerase
Chain Reaction was used to assess relative expression of
the following genes by amplification of these products: rat
LDLr, a 531 bp fragment representing nucleotides 106 to
636 [GenBank NM_175762]; rat farnesyl diphosphate
synthase (FDPS), a 656 bp fragment representing nucle-
otides 229 to 884 [GenBank NM_031840.1]; rat
GADD45, a 706 bp fragment representing nucleotides 1
to 706 [GenBank NM_024127.1]; Insig-1, a 447 bp frag-
ment representing nucleotides 1284 to 1730 [GenBank
L13619] and rat GAPDH, a 452 bp fragment representing
nucleotides 1369 to 1820 [GenBank NM_017008]. RNAs
used for Northern blot analysis were used to generate
cDNA and PCR products. Rat adult liver total RNA served
as a positive control. Three micrograms of total RNA in a
final volume of 20 μl was DNase I (Invitrogen, Carlsbad,
CA) treated at room temperature for 15 minutes and the
reaction stopped by addition of 25 mM EDTA followed by
incubation at 65 C for 10 minutes to inactivate the DNase
I enzyme. DNase treated total RNA was reverse-tran-
scribed with and without reverse transcriptase for 60 min-
utes at 50 C using Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA), Oligo (dT)12–18 (Invitrogen,
Carlsbad, CA), RNase OUT ribonuclease inhibitor (Invit-
rogen, Carlsbad, CA, and 10 mM DNTP set (Invitrogen,
Carlsbad, CA. Platinum Taq DNA polymerase (Invitrogen,
Carlsbad, CA) was used for the RT-PCR reactions, which
included 100 ng cDNA per 20 μl containing a final con-
centration of 1.5–2.25 mM MgCl2 0.2–0.3 mM dNTP, 0.5
μM each forward and reverse primers, and 0.025 U Plati-
num Taq DNA polymerase. PCR reactions were run in a
Px2 Thermal Cycler (Themo Electron Corp.). LDLr and
FDPS reactions were 94 C for 60 s followed by 94 C for 30
s, 55 C for 30 s, 72 C for 30 s (30 cycles), and a final incu-
bation at 72 C for 10 minutes. GADD45 reactions were
cycled at 94 C for 60 s, 50 C for 45 s, 72 C for 90 s for (40
cycles) and a final incubation at 72 C for 10 minutes.
Insig-1 reactions were cycled at 94 C for 30 s, 55 C for 30
s, 72 C for 90 s (35 cycles) and a final incubation at 72 C
for 10 minutes. GAPDH was cycled at 94 C for 60 s, fol-
lowed by 94 C for 30 s, 53 C for 30 s, 72 C for 30 s (30
cycles), and a final incubation at 72 C for 10 minutes.
Electrophoresis of PCR products was performed in 2%
agarose, 1× TAE gel and visualized by ethidium bromideNutrition & Metabolism 2006, 3:37 http://www.nutritionandmetabolism.com/content/3/1/37
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staining. Densitometry was run on LabWorks Software
and values were ratioed to GAPDH densitometry values.
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